Race matters for breast cancer screening protocols

More women of color in the U.S. are diagnosed with breast cancer when they're...Read more on AuntMinnie.comRelated Reading: At high risk for breast cancer? Start screening early Gap narrows in black, white breast cancer death rates USPSTF: Why do more black women die from breast cancer? Breast cancer screening gaps exist for minority women CDC: Breast cancer death rate declines, but not equally
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Abstract This chapter addresses the problem of reconstructing regulatory networks in molecular biology by integrating multiple sources of data. We consider data sets measured from diverse technologies all related to the same set of variables and individuals. This situation is becoming more and more common in molecular biology, for instance, when both proteomic and transcriptomic data related to the same set of "genes" are available on a given cohort of patients.To infer a consensus network that integrates both proteomic and transcriptomic data, we introduce a multivariate extension of Gaussian graphical ...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
New J. Chem., 2018, Accepted Manuscript DOI: 10.1039/C8NJ04695F, PaperTapan Kumar Mondal, Saswati Gharami, Krishnendu Aich, Deblina Sarkar, Paramita Ghosh, Nabendu Murmu A new ESIPT based fluorescent probe has been introduced for selective detection of Zn2+ in human breast cancer cells. The designed probe exhibits a prominent ratiometric fluorescence change along with... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - New J. Chem. latest articles - Category: Chemistry Authors: Source Type: research
Research generally does not show a link between breast cancer and testosterone in women when used primarily for hypoactive sexual desire in midlife, but better studies are needed, say the authors of a new review.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
No abstract available
Source: Oncology Times - Category: Cancer & Oncology Tags: News Source Type: research
Condition:   Triple-negative Breast Cancer Interventions:   Drug: Apatinib;   Drug: capecitabine Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Colorectal Cancer Metastatic;   Triple Negative Breast Cancer;   Non Small Cell Lung Cancer;   Bladder Cancer;   GastroEsophageal Cancer;   Renal Cell Carcinoma;   MSI-H Interventions:   Biological: EDP1503;   Biological: Pembrolizumab Sponsors:   Evelo Biosciences, Inc.;   SCRI Development Innovations, LLC;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionThese findings suggest that 99mTc-Lapachol can be a potential diagnostic agent for breast tumors.ResumenObjetivoEl cáncer de mama es un problema de salud en todo el mundo con altas tasas de incidencia y mortalidad. Es bien sabido que el desarrollo de métodos de diagnóstico más sensibles y específicos es de gran importancia, ya que un diagnóstico precoz es esencial para tratar con éxito los tumores. Lapachol es un compuesto natural, perteneciente al grupo de la naftoquinona, que se ha utilizado ampliamente en la medicina tradicional para tratar diversas enfermedades...
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research
Publication date: Available online 13 December 2018Source: Stem Cell ReportsAuthor(s): Xuanmao Jiao, Zhiping Li, Min Wang, Sanjay Katiyar, Gabriele Di Sante, Mehdi Farshchian, Andrew P. South, Cinzia Cocola, Daniele Colombo, Rolland Reinbold, Ileana Zucchi, Kongming Wu, Ira Tabas, Benjamin T. Spike, Richard G. PestellSummaryDACH1 abundance is reduced in human malignancies, including breast cancer. Herein DACH1 was detected among multipotent fetal mammary stem cells in the embryo, among mixed lineage precursors, and in adult basal cells and (ERα+) luminal progenitors. Dach1 gene deletion at 6 weeks in transgenic ...
Source: Stem Cell Reports - Category: Stem Cells Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Women